Cholecystokinin (CCK) is one of the most abundant neurotransmitter peptides in the brain. CCK appears to play an important role in the neurobiology of anxiety and panic disorders (PD) in both humans and animals. Recently, we reported that lack of CCKAR had a significant anxiogenic-like effect in rat
Association of cholecystokinin-A receptor gene polymorphisms and panic disorder in Japanese
β Scribed by Miyasaka, Kyoko ;Yoshida, Yuki ;Matsushita, Sachio ;Higuchi, Susumu ;Shirakawa, Osamu ;Shimokata, Hiroshi ;Funakoshi, Akihiro
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 56 KB
- Volume
- 127B
- Category
- Article
- ISSN
- 0148-7299
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Cholecystokinin tetrapeptide (CCKJ is known to induce panic attacks in patients with panic disorder at a lower dose than in normal controls. Therefore, the cholecystokinin B (CCKB) receptor gene is a candidate gene for panic disorder. We searched for mutations in the CCK, gene in 22 probands of pani
## Abstract The tetrapeptide of cholecystokinin (CCK), CCKβ4, is known to induce panic attacks in human subjects, while CCKβ8 is reported to have a therapeutic effect on schizophrenia symptoms. Recently, we have identified a novel microsatellite polymorphism in the 5β² upstream region of the CCK gen
We searched for mutations in the CCK gene in panic disorder with single-strand conformational polymorphism (SSCP) analysis of the three exons and promotor region of the gene. We found a C-->T transition at position -36 (CCK(-36C-->T)) in a GC box, a binding site for transcription factor Sp1, in the
## Abstract Clinical and animal studies suggest a role for pathways regulated by cyclicβAMP in anxiety. Mouse gene deletion studies, our own linkage findings on chromosome 10, and a recently published genetic association study by Domschke et al. [2003: Am J Med Genet 117B:70β78] suggest that the cA